Frailty index and frailty classification for control group (n = 7) receiving saline injections and doxorubicin-treated groups (Dox, n = 10) with 6mg/kg every four days (a total dos... by Paola Sanches Cella (4700887)

Subjects:

Oral L-Arg and D-Arg increased arginase protein expression in the liver, but L-Arg decreased it in the upper small intestine (Sm. Intes.), whereas L-Arg decreased arginase activity... by Dain (Raina) Kim (16726470)

NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

“…Right plot show the gradual decrease in the TM tuning for the features highlighted in <b>c</b> as well as the gradual increase in the temporal response profile (i.e. optimal shifts for the prediction of the key BO-NN features using Praat features shown in <b>a</b>). …”

ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

“…<p>Cos-7 cell infected with L2-euoprom-ngLVA, treated with 34 μg/ml chloramphenicol (CAM) or vehicle only (1:1000 EtOH in RPMI) at 35 hpi (arrow). …”

Surface morphologies of the Mg stent and mass loss rates. by Jeon Min Kang (12635649)

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

Subjects:

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

Subjects:

Hypothesis that explains and predicts expansion of ages of KD due to decreased IgG levels. by Hiromi Yamaguchi (2396248)

Concentrations of fatty acids in the diet (mg/100 g). by Miloš Skřivan (5122037)

Phosphatidylcholine (PC) decreases the nuclear c-Fos and c-Jun protein levels under lipopolysaccharide (LPS) stimulation in MG6 cells. by Sachiko Mizuno (21799645)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

General patient characteristics. by Ekaterina A. Bryushkova (13360122)

Subjects:

Individual dynamics of blood parameters. by Ekaterina A. Bryushkova (13360122)

Subjects:

Baseline clinical characteristics of patients. by Ekaterina A. Bryushkova (13360122)

Subjects:

Changes in CRP and LDH levels over time. by Ekaterina A. Bryushkova (13360122)

Subjects:

Minimal dataset. by Ekaterina A. Bryushkova (13360122)

Subjects:

The outcome timepoints and the mortality level of patients. by Ekaterina A. Bryushkova (13360122)

Subjects:

Dasatinib plasma pharmacokinetics in male and female VD₃ sufficient and deficient mice after a single oral gavage of 10 mg/kg dasatinib. by Kavya Annu (11587215)

Fig 10 - by Sana Khalid (132742)